产品名称 | NebuSelect™ Recombinant Human Wnt Surrogate-Fc Fusion, hFc-tag |
---|---|
目录号 | NBL-240683 |
别名 | Wnt Surrogate-Fc FusionSpeciesHuman |
外观 | see COA |
分子量 | |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | TargetWnt Surrogate-Fc Fusion |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-240683-100ug | 100ug | Inquire | Inquire | |
NBL-240683-1mg | 1mg | Inquire | Inquire | |
NBL-240683-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human Wnt Surrogate-Fc Fusion, hFc-tag
Catalog#:
NBL-240683
Description:
NebuSelect™ Recombinant Human Wnt Surrogate-Fc Fusion, hFc-tag(Cat#NBL-240683) is expressed in HEK293 with hFc tag at the C-Terminus.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 58.50 kDa. Due to glycosylation, the protein migrates to 60-75 kDa based on Bis-Tris PAGE result.
Target Name:
Wnt Surrogate-Fc FusionSpeciesHuman
Target Information:
Wnt-3a is regarded as an activator of the canonical Wnt signaling pathway. This activator is expressed in the dorsal midline region and is responsible for spinal cord development. In addition, Wnt-3a plays a regulatory role in autophagy, apoptosis, and regeneration of neurons, neurogenic inflammation and axon regeneration.Wnt-3a promotes the beta-catenin/Tcf pathway which is tumor inducing and can cause cancer when expressed in particular cell populations. It is also one of the most commonly used cytokines for organoid construction.
Amino Acid Sequence:
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.